Universal Cells Inc.
Seattle
About Universal Cells Inc.
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyte antigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $60.0K
- Funding stage: M&A
- Last round: Debt Financing (Nov 2013)
- Website: universalcells.com
- Phone: +1 425 246 5454
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/universal-cells-inc-2246026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.